Last SFr.119.90 CHF
Change Today 0.00 / 0.00%
Volume 86.0
ACIN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Frankfurt
OTC US
As of 11:43 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

acino holding ag-reg (ACIN) Snapshot

Open
SFr.119.90
Previous Close
SFr.119.90
Day High
SFr.119.90
Day Low
SFr.119.90
52 Week High
06/6/14 - SFr.120.40
52 Week Low
08/23/13 - SFr.67.00
Market Cap
414.9M
Average Volume 10 Days
97.3
EPS TTM
SFr.1.42
Shares Outstanding
3.5M
EX-Date
04/11/14
P/E TM
69.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for ACINO HOLDING AG-REG (ACIN)

Related News

No related news articles were found.

acino holding ag-reg (ACIN) Related Businessweek News

No Related Businessweek News Found

acino holding ag-reg (ACIN) Details

Acino Holding AG develops, manufactures, and markets pharmaceuticals in novel drug delivery forms worldwide. The company holds patents for various drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems, and extended release parenterals. The company offers a portfolio of pharmaceutical products for cardiovascular system, musculo-skeletal system, nervous system, urology, antianemics, diabetes, endocrine therapy, respiratory system, bile and liver therapy, and acid-related and gastrointestinal disorders, as well as anti-infectives, anti-parasitics, anti-hypertensives, vitamins, throat and nasal preparations. It also provides products for out-licensing include active ingredients, such as Alfuzosine, Amlodipine, Buprenorphine, Clopidogrel, Doxazosine, Fentanyl, Goserelin, Hydromorphone, Itraconazole, Leuprorelin, Levodopa/Carbidopa, Metoprolol, Nebivolol, and Oxycodone. In addition, the company offers customized solutions, such as product development and registration, contract manufacturing, packaging, and logistics to the pharmaceutical industry. Acino Holding AG markets its products under the Acino Switzerland brand in approximately 80 countries in the Middle East, Africa, Latin America, and Asia. The company was formerly known as Schweizerhall Holding AG and changed its name to Acino Holding AG in September 2008. Acino Holding AG is headquartered in Aesch, Switzerland. As of December 5, 2013, Acino Holding AG was taken private.

acino holding ag-reg (ACIN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

acino holding ag-reg (ACIN) Key Developments

Acino Approves Appointments to Compensation Committee

Acino announced at AGM held on June 30, 2014, the shareholders of the company approved the election of Tom Dean, Jonas Agnblad, and Dr. Håkan Björklund to the Compensation Committee.

Acino Holding AG to Report Fiscal Year 2013 Results on May 09, 2014

Acino Holding AG announced that they will report fiscal year 2013 results at 5:30 PM, Central European Standard Time on May 09, 2014

Acino Holding AG(SWX:ACIN) dropped from Swiss Performance Index (Price Return)

Acino Holding AG will be removed from Swiss Performance Index (Price Return).

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACIN:SW SFr.119.90 CHF 0.00

ACIN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACIN.
View Industry Companies
 

Industry Analysis

ACIN

Industry Average

Valuation ACIN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book 1.2x
Price/Cash Flow 22.6x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACINO HOLDING AG-REG, please visit www.acino-pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.